Nanjing Medlander Medical Technology Co. Ltd. A (688273) - Total Liabilities

Latest as of June 2025: CN¥158.97 Million CNY ≈ $23.26 Million USD

Based on the latest financial reports, Nanjing Medlander Medical Technology Co. Ltd. A (688273) has total liabilities worth CN¥158.97 Million CNY (≈ $23.26 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688273 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Nanjing Medlander Medical Technology Co. Ltd. A - Total Liabilities Trend (2020–2024)

This chart illustrates how Nanjing Medlander Medical Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688273 asset base.

Nanjing Medlander Medical Technology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Nanjing Medlander Medical Technology Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Hangzhou Kaierda Welding Robot Co Ltd SHG:688255	China	CN¥239.43 Million
China Zhonghua Geotechnical Engineering Co Ltd SHE:002542	China	CN¥4.60 Billion
Bénéteau S.A. PA:BEN	France	€708.79 Million
Better Home & Finance Holding Company NYSE:BETR	USA	$1.16 Billion
Design Therapeutics Inc NASDAQ:DSGN	USA	$12.05 Million
Kec Corporation KO:092220	Korea	₩110.89 Billion
Fine Semitech Corp KQ:036810	Korea	₩287.68 Billion
Vardhman Special Steels Limited NSE:VSSL	India	Rs-12.77 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down Nanjing Medlander Medical Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Nanjing Medlander Medical Technology Co. balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanjing Medlander Medical Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)

The table below shows the annual total liabilities of Nanjing Medlander Medical Technology Co. Ltd. A from 2020 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥199.66 Million ≈ $29.22 Million	+25.89%
2023-12-31	CN¥158.60 Million ≈ $23.21 Million	+11.72%
2022-12-31	CN¥141.96 Million ≈ $20.77 Million	+22.38%
2021-12-31	CN¥116.01 Million ≈ $16.98 Million	+30.81%
2020-12-31	CN¥88.69 Million ≈ $12.98 Million	--

About Nanjing Medlander Medical Technology Co. Ltd. A

SHG:688273 China Medical Devices

Market Cap

$430.65 Million

CN¥2.94 Billion CNY

Market Cap Rank

#13155 Global

#3944 in China

Share Price

CN¥29.43

Change (1 day)

-2.13%

52-Week Range

CN¥26.64 - CN¥61.22

All Time High

CN¥61.22